Free Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Taiwan Government criticised for delaying approval of HTPs ...
  • Spain Public consultation on nic pouch and herbal heated product regulation ...
  • Europe European Parliament adopts motion for a resolution on Council recommendation ...
  • Europe Agreement on EC composition could include new health commissioner ...
  • Italy - Romania - Spain Italy and Romania concerned about procedure leading to Council recommendations ...
  • Europe Public usage restrictions on novel inhalable products could be approved soon ...
  • Iceland New excise duties for pouches to be based on nicotine concentration ...
  • United States Class action filed against Swedish Match ...
  • New Zealand Smokefree Environments Bill adopted in second reading ...
  • Thailand New QR system to track cigarettes not expected to impact oral tobacco ...
  • Ohio - United States City attorney sues tobacco retailer over sales of flavours and to minors ...
  • United States Trump critical of FDA in announcement of health secretary nomination ...
View all
News analysis

Healthy business? PMI completes its takeover of Vectura and Fertin Pharma

Written by || 16th September 2021 || News analysis | Major brands | GeographiesDenmark Europe United Kingdom

Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, becoming its majority shareholder, along with that of the Danish oral-products manufacturer Fertin Pharma.

Confirming the completion of the deal today, Vectura, which develops and manufactures inhalers, said that the offer from the Big Tobacco company – £1.65 per share – now becomes “unconditional in all respects”, meaning the remaining stakeholders cannot prevent it.

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Author default picture

David Palacios Rubio

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.